Insights on the acetylated NF-κB transcription factor complex with DNA from molecular dynamics simulations

Proteins: Structure, Function and Bioinformatics

Volumn 80, Issue 6, 2012, Pages 1560-1568

  Fenollar Ferrer, Cristina ^a   Anselmi, Claudio ^a   Carnevale, Vincenzo ^b   Raugei, Simone ^c   Carloni, Paolo ^d  

^a MAX PLANCK INSTITUTE OF BIOPHYSICS   (Germany)

^b Temple University   (United States)

^c PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

^d FORSCHUNGSZENTRUM JÜLICH   (Germany)

Author keywords

DNA binding affinity; Lysine acetylation; MD; Post translational modifications; Transcription factor; Transcription regulation

Indexed keywords

DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYSINE; PROTEIN P50; SODIUM ION; SYNAPTOTAGMIN I;

ACETYLATION; AQUEOUS SOLUTION; ARTICLE; DNA BINDING; ENTROPY; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; STATIC ELECTRICITY;

ACETYLATION; ANIMALS; CRYSTALLOGRAPHY, X-RAY; DNA; IMMUNOGLOBULINS; MICE; MOLECULAR DYNAMICS SIMULATION; NF-KAPPA B P50 SUBUNIT; PROTEIN BINDING; SODIUM; THERMODYNAMICS; TRANSCRIPTION FACTOR RELA;

EID: 84860645803     PISSN: 08873585     EISSN: 10970134     Source Type: Journal    
DOI: 10.1002/prot.24047     Document Type: Article

References (45)

1. Baldwin AS, Jr. The NF-κB and IκB proteins: new discoveries and insights. Annu Rev Immunol 1996; 14: 649-683.
2. Grilli M, Memo M. Nuclear factor-κB/Rel proteins: a point of convergence of signalling pathways relevant in neuronal function and dysfunction. Biochem Pharmacol 1999; 57: 1-7.
3. O'Neill LA, Kaltschmidt C. NF-κB: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci 1997; 20: 252-258.
4. Chen FE, Ghosh G. Regulation of DNA binding by Rel/NF-κB transcription factors: structural views. Oncogene 1999; 18: 6845-6852.
5. Ghosh S, May MJ, Kopp EB. NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998; 16: 225-260.
6. Kiernan R, Bres V, Ng RW, Coudart MP, El Messaoudi S, Sardet C, Jin DY, Emiliani S, Benkirane M. Post-activation turn-off of NF-κB-dependent transcription is regulated by acetylation of p65. J Biol Chem 2003; 278: 2758-2766.
7. Rayet B, Gelinas C. Aberrant rel/nfkb genes and activity in human cancer. Oncogene 1999; 18: 6938-6947.
8. Cahir McFarland ED, Izumi KM, Mosialos G. Epstein-barr virus transformation: involvement of latent membrane protein 1-mediated activation of NF-κB. Oncogene 1999; 18: 6959-6964.
9. Kucharczak J, Simmons MJ, Fan Y, Gelinas C. To be, or not to be: NF-κB is the answer - role of Rel/NF-κB in the regulation of apoptosis. Oncogene 2003; 22: 8961-8982.
10. Inoue J, Gohda J, Akiyama T, Semba K. NF-κB activation in development and progression of cancer. Cancer Sci 2007; 98: 268-274.
11. Ito K. Impact of post-translational modifications of proteins on the inflammatory process. Biochem Soc Trans 2007; 35: 281-283.
12. Mohamed MR, McFadden G. NFκB inhibitors: strategies from poxviruses. Cell Cycle 2009; 8: 3125-3132.
13. Perkins ND. The Rel/NF-κB family: friend and foe. Trends Biochem Sci 2000; 25: 434-440.
14. Magné N, Toillon RA, Bottero V, Didelot C, Houtte PV, Gerard JP, Peyron JF. NF-κB modulation and ionizing radiation: mechanisms and future directions for cancer treatment. Cancer Lett 2006; 231: 158-168.
15. Namba H, Saenko V, Yamashita S. Nuclear factor-kB in thyroid carcinogenesis and progression: a novel therapeutic target for advanced thyroid cancer. Arq Bras Endocrinol Metabol 2007; 51: 843-851.
16. Cilloni D, Martinelli G, Messa F, Baccarani M, Saglio G. Nuclear factor kB as a target for new drug development in myeloid malignancies. Haematologica 2007; 92: 1224-1229.
17. Chen LF, Fischle W, Verdin E, Greene WC. Duration of nuclear NF-κB action regulated by reversible acetylation. Science 2001; 293: 1653-1657.
18. Chen LF, Mu Y, Greene WC. Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-κB. EMBO J 2002; 21: 6539-6548.
19. Sheppard KA, Rose DW, Haque ZK, Kurokawa R, McInerney E, Westin S, Thanos D, Rosenfeld MG, Glass CK, Collins T. Transcriptional activation by NF-κB requires multiple coactivators. Mol Cell Biol 1999; 19: 6367-6378.
20. Vanden Berghe W, De BK, Boone E, Plaisance S, Haegeman G. The nuclear factor-κB engages CBP/p300 and histone acetyltransferase activity for transcriptional activation of the interleukin-6 gene promoter. J Biol Chem 1999; 274: 32091-32098.
21. Roth SY, Denu JM, Allis CD. Histone acetyltransferases. Annu Rev Biochem 2001; 70: 81-120.
22. Furia B, Deng L, Wu K, Baylor S, Kehn K, Li H, Donnelly R, Coleman T, Kashanchi F. Enhancement of nuclear factor-κB acetylation by coactivator p300 and HIV-1 Tat proteins. J Biol Chem 2002; 277: 4973-4980.
23. Chen LF, Greene WC. Regulation of distinct biological activities of the NF-κB transcription factor complex by acetylation. J Mol Med 2003; 81: 549-557.
24. Deng WG, Zhu Y, Wu KK. Up-regulation of p300 binding and p50 acetylation in tumor necrosis factor-α-induced cyclooxygenase-2 promoter activation. J Biol Chem 2003; 278: 4770-4777.
25. Schmitz ML, Mattioli I, Buss H, Kracht M. NF-κB: a multifaceted transcription factor regulated at several levels. ChemBioChem 2004; 5: 1348-1358.
26. Quivy V, Van Lint C. Regulation at multiple levels of NF-κB-mediated transactivation by protein acetylation. Biochem Pharmacol 2004; 68: 1221-1229.
27. Chen LF, Greene WC. Shaping the nuclear action of NF-κB. Nat Rev Mol Cell Biol 2004; 5: 392-401.
28. Chen FE, Huang DB, Chen YQ, Ghosh G. Crystal structure of p50/p65 heterodimer of transcription factor NF-κB bound to DNA. Nature 1998; 391: 410-413.
29. Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML. Comparison of simple potential functions for simulating liquid water. J Chem Phys 1983; 79: 926-935.
30. Wang J, Cieplak P, Kollman PA. How well does a restrained electrostatic potential (RESP) model perform in calculating conformational energies of organic and biological molecules? J Comput Chem 2000; 21: 1049-1074.
31. Ponder JW, Case DA. Force fields for protein simulations. Adv Protein Chem 2003; 66: 27-85.
32. Bayly CI, Cieplak P, Cornell WD, Kollman PA. A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges: the RESP model. J Phys Chem 1993; 97: 10269-10280.
33. Berendsen HJC, van der Spoel D, van Drunen R. GROMACS:a message-passing parallel molecular dynamics implementation. Comp Phys Commun 1995; 91: 43-56.
34. Lindhal E, Hess B, van der Spoel D. GROMACS 3.0: a package for molecular simulation and trajectory analysis. J Mol Mod 2001; 7: 306-317.
35. Humphrey W, Dalke A, Schulten K. VMD: visual molecular dynamics. J Mol Graph 1996; 14: 33-38.
36. Lavery R, Sklenar H. Defining the structure of irregular nucleic acids: conventions and principles. J Biomol Struct Dyn 1989; 6: 655-667.
37. Anselmi C, De Santis P, Paparcone R, Savino M, Scipioni A. From the sequence to the superstructural properties of DNAs. Biophys Chem 2002; 95: 23-47.
38. Olson WK, Bansal M, Burley SK, Dickerson RE, Gerstein M, Harvey SC, Heinemann U, Lu XJ, Neidle S, Shakked Z, Sklenar H, Suzuki M, Tung CS, Westhof E, Wolberger C, Berman HM. A standard reference frame for the description of nucleic acid base-pair geometry. J Mol Biol 2001; 313: 229-237.
39. Baker NA, Sept D, Joseph S, Holst MJ, McCammon JA. Electrostatics of nanosystems: application to microtubules and the ribosome. Proc Natl Acad Sci U S A 2001; 98: 10037-10041.
40. Kollman PA, Massova I, Reyes C, Kuhn B, Huo S, Chong L, Lee M, Lee T, Duan Y, Wang W, Donini O, Cieplak P, Srinivasan J, Case DA, Cheatham TE, III. Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. Acc Chem Res 2000; 33: 889-897.
41. Case DA, Darden TA, Cheatham TE, III, Simmerling CL, Wang J, Duke RE, Luo R, Walker RC, Zhang W, Merz KM, Roberts BP, Wang B, Hayik S, Roitberg A, Seabra G, Kolossvai I, Wong KF, Paesani F, Vanicek J, Liu J, Wu X, Brozell SR, Steinbrecher T, Gohlke H, Cai Q, Ye X, Wang J, Hsieh M-J, Cui G, Roe DR, Mathews DH, Seetin MG, Sagui C, Babin V, Luchko T, Gusarov S, Kovalenko A, Kollman PA. AMBER 11. In. San Francisco: University of California; 2010.
42. Hartmann B, Piazzola D, Lavery R. BI-BII transitions in B-DNA. Nucleic Acids Res 1993; 21: 561-568.
43. Falvo JV, Thanos D, Maniatis T. Reversal of intrinsic DNA bends in the IFN β gene enhancer by transcription factors and the architectural protein HMG I(Y). Cell 1995; 83: 1101-1111.
44. Perez A, Marchan I, Svozil D, Sponer J, Cheatham TE, III, Laughton CA, Orozco M. Refinement of the AMBER force field for nucleic acids: improving the description of alpha/gamma conformers. Biophys J 2007; 92: 3817-3829.
45. Schlitter J. Estimation of absolute and relative entropies of macromolecules using the covariance-matrix. Chem Phys Lett 1993; 215: 617-621.